Related Experiment Video
Updated: May 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Acute hepatitis C: management in the rapidly evolving world of HCV
Suraj A Sharma1, Jordan J Feld
1Toronto Center for Liver Disease, Sandra Rotman Centre for Global Health, University Health Network, University of Toronto, 6B-Fell Pavilion, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada.
Insights
Recognizing acute hepatitis C virus (HCV) infection is crucial for timely treatment, as many patients are asymptomatic. Early intervention improves outcomes and prevents chronic liver disease.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) infection's acute phase is typically 6 months but can extend.
- Most acute HCV infections are asymptomatic, delaying diagnosis until chronic disease develops.
- HCV can lead to decompensated cirrhosis or hepatocellular carcinoma (HCC) decades after initial infection.
Purpose of the Study:
- To review the epidemiology, natural history, diagnosis, and treatment of acute HCV infection.
- To highlight the importance of identifying acute HCV for effective treatment.
- To discuss the potential impact of new all-oral therapies on acute HCV management.
Main Methods:
- Literature review focusing on acute hepatitis C.
- Analysis of epidemiological data and natural history studies.
- Evaluation of diagnostic and treatment strategies for acute HCV.
Main Results:
- A significant proportion (20-40%) of patients spontaneously clear HCV during the acute phase.
- Interferon-based treatment is more effective in the acute phase but poorly tolerated.
- Delayed diagnosis is common due to asymptomatic presentation.
Conclusions:
- Early recognition of acute HCV is critical for initiating therapy in non-clearing patients.
- Emerging all-oral therapies may change the management paradigm for acute HCV.
- Further research is needed to optimize diagnosis and treatment strategies for acute HCV infection.
Abstract:
The acute phase of hepatitis C (HCV) infection is typically defined as the initial 6 months following exposure to the virus; however, in some individuals, the acute phase of the infection can last much longer (Orland et al. Hepatology 33:321-27, 2001). Although some patients have symptoms of acute hepatitis, most infected individuals are entirely asymptomatic. As a result, many patients are unaware of the infection until it progresses to chronic infection, and may not develop symptoms until decades later with the onset of decompensated cirrhosis or hepatocellular carcinoma (HCC). A substantial proportion (20-40%) of infected patients clear the virus during the acute phase. Interferon-based treatment is also much more likely to be successful in the acute phase of infection but is relatively poorly tolerated. Therefore, recognition of acute HCV infection is critical to prioritize those patients who do not spontaneously clear the infection for immediate therapy. However, the promise of highly effective well-tolerated all-oral therapies in development may alter the management approach. This review will focus on the epidemiology, natural history, diagnosis, and treatment of acute HCV infection.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis III: Medical Management
Cystic Fibrosis: Management
Sinus disease and chronic...